Committee Connection
  • JCO Exclusive: In Sorafenib-Treated HCC, Prophylactic Use of Urea-Based Cream Improves Hand-Foot Skin Reaction

    02 Mar 2015 03:53 PM

                        Key Points The study found that over a 14-week period, incidence of HFSR—of any grade—was lower among patients who started using the urea-based cream at the start of treatment, compared to patients who received best supportive care alone. The Incidence of HFSR of grade 2 or higher was also lower among the prophylactic group. Patients who used the... Read more

  • JCO Exclusive: First Meta-Analysis of Ipilimumab Demonstrates Sustained Long-Term Benefits

    23 Feb 2015 03:55 PM

                        Key Points A meta-analysis of 12 studies examined the long-term survival benefits of the immunotherapy drug ipilimumab for the treatment of advanced melanoma. The study found that 22% of the 1,861 patients (n=254) in the studies were alive three years after treatment. Among that 22% of patients, the survival curve reached a plateau at year three,... Read more

  • JCO Exclusive: Does Aggressive Surgery for Ovarian Cancer Always Lead to Better Outcomes?

    09 Feb 2015 04:29 PM

                        Key Points The study found that among 2,655 patients with ovarian cancer who had achieved optimal debulking, patients with higher disease distribution and higher post-surgery residual disease had worse outcomes, independent of the type of surgery received. Residual disease made a difference in outcomes: All patients, including those with high disease... Read more

  • JOP Exclusive: Are Fertility Discussion with Adolescents and Young Adult Patients with Cancer Happening?

    02 Feb 2015 03:59 PM

                        Key Points This study found that 26% or participants had documented discussions of fertility risk, 24% had documented discussions of fertility preservation, and 13% had documented referral to a fertility specialist. This is far below the ASCO Quality Oncology Practice Initiative (QOPI) suggested rated of 80%. There was a significantly lower rate of... Read more

  • JCO Exclusive: Can Oncology Communication Skills Be Learned? Yes, Says One Study

    26 Jan 2015 04:05 PM

                        Key Points The study found that members of four interdisciplinary radiology teams who took part in a 38-hour training program designed to strengthen skills in patient communication showed improvements in patient-assessment skills, supportive skills, and in the amount of information shared with patients during a radiology planning session among patients... Read more

  • JCO Exclusive: Study Shows Immunotherapy Response in Patients with Pancreatic Cancer

    12 Jan 2015 04:04 PM

                        Key Points This study reported that immunotherapy can confer a possible survival advantage in patients with pancreatic cancer. The study compared combined GVAX/CRS-207 to GVAX alone and found that the 61 patients who received the combined treatment had an overall survival (OS) of 6.1 months, whereas the 29 patients who received GVAX alone had an OS of 3.9... Read more

  • JOP Exclusive: Success Seen in NCI Multidisciplinary Care Program

    05 Jan 2015 04:15 PM

                        Key Points This study reported on the progress of the National Cancer Institute Community Cancer Centers Program (NCCCP), established in 2007 with the goal of improving the quality of care in community cancer centers. One of the major goals of the NCCCP was to encourage the development of multidisciplinary clinics (MDCs ) in community cancer centers.... Read more

  • Cancer Survivorship: Optimizing Care and Outcomes through Continuing Medical Education

    05 Jan 2015 11:00 AM

    By Larissa Nekhlyudov, MD, MPH, and Ann Partridge, MD, MPH, Dana-Farber Cancer Institute, Harvard Medical School     Larissa Nekhlyudov, MD, MPH Ann Partridge, MD, MPHTraditional approaches to caring for cancer survivors have focused primarily on surveillance for recurrence. In recent years, sparked by the 2006 Institute of Medicine report, this focus has expanded to include health promotion, prevention, and surveillance... Read more

  • JCO Exclusive: In Detecting Prostate Cancer, a New Biomarker May Supplement PSA

    29 Dec 2014 04:03 PM

                        Key Points This study of 859 men who were previously screened for prostate cancer found that using the urinary biomarker PCA3 as a supplement to the PSA test led to a more refined measurement of risk, for both prostate cancer and high-grade cancer, compared to using PSA alone. The study found that for men who never had a biopsy and who had an elevated... Read more

  • JOP Exclusive: Financial Burden in Pediatric Cancer May be Tied to Unexpected Events

    22 Dec 2014 04:00 PM

                        Key Points This study found that caregivers whose children or charges experienced five or more unexpected hospitalizations during the first to fifth year after diagnosis reported a perceived financial distress 24.9 points higher (out of a scale of 100) than those who had fewer hospitalizations  Caregivers who had quit or changed jobs within years... Read more